Found: 6
Select item for more details and to access through your institution.
Disease-Modifying Immunotherapy for the Management of Autoimmune Diabetes.
- Published in:
- Neuroimmunomodulation, 2010, v. 17, n. 3, p. 173, doi. 10.1159/000258716
- By:
- Publication type:
- Article
Pluripotent Nontumorigenic Adipose Tissue-Derived Muse Cells have Immunomodulatory Capacity Mediated by Transforming Growth Factor-β1.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 1, p. 161, doi. 10.5966/sctm.2016-0014
- By:
- Publication type:
- Article
A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14.
- Published in:
- Nature Medicine, 2007, v. 13, n. 1, p. 38, doi. 10.1038/nm1528
- By:
- Publication type:
- Article
Effect of TGF-β1 Stimulation on the Secretome of Human Adipose-Derived Mesenchymal Stromal Cells.
- Published in:
- Stem Cells Translational Medicine, 2015, v. 4, n. 8, p. 894, doi. 10.5966/sctm.2015-0012
- By:
- Publication type:
- Article
Compound A attenuates proinflammatory cytokine-induced endoplasmic reticulum stress in beta cells and displays beneficial therapeutic effects in a mouse model of autoimmune diabetes.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 12, p. 1, doi. 10.1007/s00018-022-04615-5
- By:
- Publication type:
- Article
Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 2, p. 141
- By:
- Publication type:
- Article